Nagla Abdel Karim: Advances in molecular targets for NSCLC

Nagla Abdel Karim: Advances in molecular targets for NSCLC

Nagla Abdel Karim shared the following on X:

“Mariam Alexander presents all about before & after molecular targets in resectable NSCLC. Neoadjuvant Target Therapies awaiting more data.”

Nagla Abdel Karim: Advances in molecular targets for NSCLC

cancer DC Lung 24 DCLung24 Mariam Alexander Nagla Abdel Karim neoadjuvant therapy NSCLC OncoDaily Oncology